Inspection Readiness Playbook – Handling Hazardous Biological Samples
Inspection Readiness Playbook – Handling Hazardous Biological Samples Inspection Readiness Playbook – Handling Hazardous Biological Samples Introduction: The Risk of Hazardous Sample Mismanagement Clinical trials involving infectious diseases, gene therapy, or immune-modulating therapies often require collection and transport of hazardous biological samples such as blood, sputum, cerebrospinal fluid, or genetically modified organisms (GMOs). Mismanagement of…
Read More “Inspection Readiness Playbook – Handling Hazardous Biological Samples” »